Immune checkpoint inhibitor-associated pneumonitis in patients with thoracic malignancy: Multicenter prospective observational study
Not Applicable
Recruiting
- Conditions
- thoracic malignancy
- Registration Number
- JPRN-UMIN000039761
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 800
Inclusion Criteria
Not provided
Exclusion Criteria
nothing
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The incidence of immune checkpoint inhibitor-associated pneumonitis
- Secondary Outcome Measures
Name Time Method Risk factors for the development of immune checkpoint inhibitor-associated pneumonitis